- Idiopathic granulomatous mastitis (IGM):
- Is a rare benign inflammatory breast disease first described in 1972 by Kessler and Wolloch
- The most common presenting symptom is:
- A unilateral, firm, and discrete breast mass:
- Which may be accompanied by overlying skin changes and / or possible lymph node involvement with idiopathic granulomatous mastitis
- The average duration of symptoms is around 3.9 months with:
- The most common signs and symptoms including discrete mass, tenderness to palpation, erythema, and swelling
- The pain could be out of proportion to findings:
- Suggestive of a localized ischemic etiology
- The pain could be a motivating factor in prompting all symptomatic patients to seek consultation
- The lesion may occur in any quadrant of the breast:
- But often extends radially from the retroareolar region
- A unilateral, firm, and discrete breast mass:
- The disease often presents in women:
- Of childbearing age with a recent history of pregnancy or ongoing lactation:
- The mean age of diagnosis is around 31.7 years and all within reproductive years
- The high majority of women are Hispanic or African / African-American ancestry
- A history of previous granulomatous disease (tuberculosis, sarcoidosis, autoimmune disease, or granulomatous disease) is very rare
- Of childbearing age with a recent history of pregnancy or ongoing lactation:
- The overlap of presenting symptoms with other disease processes such as:
- Malignancy, acute or chronic infections, and chronic inflammatory diseases:
- Makes definitive diagnosis difficult
- Malignancy, acute or chronic infections, and chronic inflammatory diseases:
- Because the differential may include malignancy:
- The patient may experience significant anxiety during the evaluation
- In addition, the broad differential and the lack of pathognomonic features make definitive diagnosis difficult:
- Often resting as a diagnosis of exclusion on a clinical basis
- The typical mammographic and ultrasonographic findings of granulomatous mastitis are:
- Mammogram:
- Ill-defined mass to an asymmetric density without specific margins
- It is usually not accompanied by microcalcifications or architectural distortion
- Mammogram:
- Ultrasound:
- Heterogeneously hypoechoic lesion
- Segmental masses with ill-defined margins, with tubular structures extending from the mass:
- The tubular structures may be clustered, separate or contiguous
- Malignant features or findings:
- Suspicious microcalcifications, architectural distortion, or intra-ductal mass:
- Would warrant appropriate histologic diagnosis and subsequent management
- Suspicious microcalcifications, architectural distortion, or intra-ductal mass:
- If the findings clinically and radiographically indicate an abscess:
- They warrant treatment with antibiotics along with drainage by aspiration or incision, if the abscess is larger
- Idiopathic granulomatous mastitis is usually regarded as a sterile process:
- However, there is evidence to suggest a link to Corynebacterium kroppenstedtii infection or colonization:
- This would then mandate routine cultures
- One-third of the patients with granulomatous mastitis who are evaluated:
- Have findings suggestive of an abscess
- However, there is evidence to suggest a link to Corynebacterium kroppenstedtii infection or colonization:
- Because diagnosis is difficult, patients typically have received:
- Prolonged courses of antibiotics, frequent biopsies, or surgical procedures
- With a lack of pathognomonic imaging findings associated with granulomatous mastitis:
- Histopathology is key to confirming a diagnosis
- Histologically:
- The disease has been described as non-caseating granulomas among epithelioid histiocytes and multinucleated giant cells surrounded by lymphocytes and plasma cells
- Histologic differentials begin with the use of:
- Hematoxylin and eosin stains, gram stain, and may also include acid fast stains and Grocott’s methenamine silver to evaluate for the possibility of sarcoidosis or mycobacterium infection
- Once the diagnosis is made, treatment strategies are not clearly delineated but are often supportive
- Steroid treatment has been shown to decrease the extent of involvement, and enable complete resection with removal of less breast tissue should resection be pursued
- However, lower doses have also proven to be efficacious and help to avoid adverse effects of weight gain, hyperglycemia, and Cushingoid symptoms
- Regimens of 16 mg of prednisone twice a day for two weeks with a slow taper over a two-month period are described in the literature, as is prednisolone 30 mg/day for eight weeks, with taper
- If symptoms do not improve, a course of methotrexate could be utilized:
- Since there is a contingent who feel that this disease is an abnormal immune response
- Success with methotrexate, including administration in steroid refractory cases:
- Is limited to small studies of 3 to 5 patients
- In consideration of the duration of symptoms patients experienced, along with the lack of durable evidence favoring treatment with methotrexate, our institution favors proceeding directly to surgery in steroid-refractory cases
- We recommend the surgical options of:
- Wide local excision for focal involvement and
- Total mastectomy with the option of reconstruction for diffuse involvement
- A 15% to 20% recurrence rate has been reported for surgery alone:
- And inversely proportional to negative surgical margins
- In light of the fact that these masses are painful and may lead to fistula formation and deformity:
- Intervention may be the preferred path to avoid progression or static disease
- Our experience allowed for a trial of “conservative” medical management for two months:
- Followed by treatment escalation for lack of progress
- A course of methotrexate may be entertained in patients who desire continued attempts at medical management, to help preserve breast tissue
- However, it is not included in the first line of conservative management


#Arrangoiz #BreastSurgeon #BreastCancer #IGM #IdiopathicGranulamatousMastitis #CASO #Miami #CenterforAdvancedSurgicalOncology #CancerSurgeon